CD36 and atherosclerosis: Though previously CD36 has been implicated in metabolic dysregulation-associated pathological conditions (43–45), further studies are recommended to elucidate the role of CD36-mediated exosomal delivery of FFAs in the pathogenesis of obesity, diabetes, and atherosclerosis.